U.S. court expedites Indivior rival's appeal to re-launch generic drug

Indivior said on Monday a U.S. Court expedited a generic rival's appeal against a preliminary injunction that blocked the sale of a copycat version of the British drugmaker's blockbuster opioid addiction treatment.